4 Results for "

wild-type PI3Kα

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "wild-type PI3Kα" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-101562
CAS No.: 2060571-02-8
Purity:  99.96%
Synonyms: GDC-0077; RG6114
Target:  

PI3K Apoptosis

Research Areas:  

Cancer

Inavolisib (GDC-0077) is a potent, orally active, and selective PI3Kα inhibitor (IC50=0.038 nM). Inavolisib exerts its activity by binding to the ATP binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3. Inavolisib is more selective for mutant versus wild-type PI3Kα. Inavolisib can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-184099
CAS No.: 3031974-57-6
Synonyms: zinilisibum
Target:  

PI3K Akt

Research Areas:  

Cancer

Zinilisib (Zinilisibum) is a PI3K inhibitor. Zinilisib potently inhibits the phosphorylation of AKT in cells expressing mutant PI3Kα H1047R and wild-type PI3Kα, with IC50 values of 1-500 nM and 2-15 μM, respectively. Zinilisib can be used in breast cancer-related research .
loading...
    loading...
Cat. No.: HY-182946
CAS No.: 3115133-30-4
Target:  

PI3K

Research Areas:  

Cancer

PI3Kα-IN-31 is an orally active and selective PI3Kα inhibitor. PI3Kα-IN-31 shows potent preference for mutant PI3Kα over wild-type PI3Kα. PI3Kα-IN-31 exerts antiproliferative effects in PI3Kα-mutant cancer cells. PI3Kα-IN-31 suppresses tumor growth in xenograft models. PI3Kα-IN-31 can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-101562R
CAS No.: 2060571-02-8
Synonyms: GDC-0077 (Standard); RG6114 (Standard)
Research Areas:  

Cancer

Inavolisib (Standard) is the analytical standard of Inavolisib (HY-101562). This product is intended for research and analytical applications. Inavolisib (GDC-0077) is a potent, orally active, and selective PI3Kα inhibitor (IC50=0.038 nM). Inavolisib exerts its activity by binding to the ATP binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3. Inavolisib is more selective for mutant versus wild-type PI3Kα. Inavolisib can be used for the study of breast cancer .
loading...
    loading...